ICOS critically regulates the expansion and function of inflammatory human Th17 cells

Details for Australian Patent Application No. 2011212794 (hide)

Owner The Trustees of the University of Pennsylvania

Inventors Riley, James L.; Paulos, Chrystal; June, Carl H.; Levine, Bruce

Agent Pizzeys

Pub. Number AU-A-2011212794

PCT Pub. Number WO2011/097477

Priority 61/301,506 04.02.10 US

Filing date 4 February 2011

Wipo publication date 11 August 2011

International Classifications

A61K 39/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 35/12 Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/097477 Priority application(s): WO2011/097477

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011212805-Method and system for controlling mercury emissions from coal-fired thermal processes

2011212790-Ruggedized fiber optic/electrical connection system